AstraZeneca to Establish Global Drug Research Center in Beijing
Britain’s AstraZeneca wants to invest $2.5 billion in Beijing, China to establish its sixth global strategic R&D center.
investment
Arkema Launches Acrylic Acid Purification Project
Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.
Syngene Acquires its First US Manufacturing Facility
Syngene, a global contract research, development, and manufacturing organization (CRDMO), recently announced the acquisition of its first biologics site in the USA – fitted with multiple monoclonal antibody (mAbs) manufacturing lines.
Axplora Expands Capabilities at Le Mans Site
Axplora, an API small molecule and ADC (antibody-drug conjugate) manufacturer, is strengthening its position in the commercial manufacturing ADCs by launching a cutting-edge payload manufacturing workshop at its Le Mans site (France).
Adragos Pharma Commissions New Liquid Filling Line at German Site
German contract development and manufacturing organization (CDMO) Adragos Pharma has completed a €4 million project to install and commission a new, cGMP-compliant liquid drug filling line and associated cartoning machine at its plant in Leipzig, Germany.
CordenPharma Expands Peptide Manufacturing Platform in Switzerland
Contract development and manufacturing organization (CDMO) CordenPharma has finalized plans to establish a new peptide manufacturing facility in Switzerland located at Getec Park in Muttenz near Basel. This investment is part of the company’s growth initiatives with a more than €1 billion strategic investment in peptide development and manufacturing.
Toray Opens R&D Center in Taiwan for Semiconductors
Toray Industries has opened the Toray Taiwan Technical Center. This new facility aims to enhance research and development in advanced semiconductor technologies and materials, and provide technical services in the Taiwan market, which plays a significant role in the global semiconductor supply chain.
Lilly to Expand US Drug Manufacturing with $27 Billion Investment
Eli Lilly plans to invest $27 billion to bolster its domestic medicine production across several therapeutic areas by building four new manufacturing sites in the US.
Arkema to Increase its PVDF Capacity in North America
The 15% capacity expansion of Arkema’s PVDF production site in Calvert City, Kentucky, represents an investment of approximately $20 million (€19 million).
BASF Expands Cellasto MCU Production in India
BASF India Ltd. has broken ground on a new plant to increase the production capacity of its Cellasto microcellular polyurethane (MCU) in Dahej, India.
Nouryon Doubles Capacity of Chromatography Media in Sweden
Nouryon plans to expand its chromatography media manufacturing facility in Bohus, Sweden, doubling the site’s capacity. Construction will begin in early 2025, and the start of production is expected in early 2027, the company said.
Henkel Opens New Application Center in South Korea
Henkel recently announced the opening of its new Application Center in Busan, South Korea, marking a significant investment in the global sports & fashion industry.
Lanxess Opens Application Development Center in India
German specialty chemicals company Lanxess inaugurated its India Application Development Center (IADC) in Mumbai.
TotalEnergies and Air Liquide to Invest €1 Billion in Dutch Green Hydrogen Projects
TotalEnergies and Air Liquide have signed agreements to develop two projects in the Netherlands, for the production and delivery of some 45,000 t/y of green hydrogen produced using renewable power, generated mostly by the OranjeWind offshore wind farm, developed by TotalEnergies (50%) and RWE (50%).
Fujifilm Ramps up Capacity for Semiconductor Materials in Belgium
Fujifilm plans to invest approximately €25 million to install new production facilities for chemical mechanical planarization (CMP) slurries, which are used in advanced semiconductors, as well as enhance existing facilities for photolithography-related materials at its site in Antwerp, Belgium.
First Companies to Produce at Oman’s Ladayn Polymer Park
Global integrated energy group OQ announced that three companies, representing a combined investment of $42 million, will start operations at Oman’s Ladayn Polymer Park in early 2025.
Repsol Greenlights €800 Million Ecoplant Investment
Spanish energy and petrochemicals group Repsol has approved an investment of more than €800 million to build its Ecoplant in the area of Tarragona, Spain. The first of its kind in Europe, the facility will use urban waste to produce renewable fuels and circular products through gasification, the company said.
Upperton Completes Sterile Manufacturing Facility in UK
UK contract development and manufacturing organization (CDMO) Upperton Pharma Solutions, has completed its new sterile manufacturing facility in Nottingham, UK, expanding its capacity in addition to its existing 50,000-square-foot site at Trent Gateway.
Solvias Opens New Testing Center in North Carolina, US
Solvias, a Switzerland-headquartered provider of chemistry, manufacturing, and control (CMC) analytics, has opened the first phase of its 50,000-square-foot testing center for biologics and cell and gene therapy in Research Triangle Park (RTP), North Carolina, US.
AstraZeneca Plans $570 Million Investment in Canada
To support the move to a larger office facility in the Greater Toronto Area, Ontario, AstraZeneca plans to invest $570 million in Canada, creating more than 700 jobs.
Amgen Opens New Drug Substance Facility in the US
At the end of last week, US biotech Amgen officially opened its newest drug substance facility in Holly Springs, North Carolina, US. The opening day also saw the groundbreaking of a further $1 billion expansion at the North Carolina site, announced less than two months ago.
AkzoNobel Invests €22 Million Streamlining France Operations
AkzoNobel has proposed a €22 million investment to make its Montataire site a flagship for decorative paint production in France.
Carbios Postpones Construction of PET Bio-Recycling Facility in France
French green chemistry company Carbios announced that it is postponing the construction of its PET bio-recycling plant in Longlaville for six to nine months due to delayed funding pending completion of additional financing under satisfactory conditions. The company aims to complete the financing as soon as possible to meet market needs from 2027. Carbios expects to sign several binding commercial contracts in the first half of 2025.
Messer Starts Operation of New Green CO2 Plant in Czechia
German family-owned industrial gases producer Messer has started operations at a new plant for the production of green carbon dioxide (CO2) at its Vrdy site in the Czech Republic.
Toray to Build Pilot Facility for All-Carbon CO2 Separation Membrane in Japan
Japan’s Toray Industries plans to install a pilot facility for its all-carbon carbon dioxide (CO2) separation membrane at its plant in Shiga, Japan.
Clariant Starts New Additives Line in China
Clariant is expanding its Cangzhou production site to manufacture the multifunctional additive Nylostab S-EED.
Novo Nordisk to Build New Production Facility in Odense, Denmark
Danish drugmaker Novo Nordisk plans to invest 8.5 billion Danish kroner (about €1.14 billion) to establish a new production facility in Odense, Denmark.
Greensand CCS Project Partners Take Final Investment Decision
Ineos and its partners Harbour Energy and Nordsøfonden have taken the final investment decision (FID) into the first commercial phase ‘Greensand Future’ with storage operations in a depleted oil field in the Danish North Sea set to begin at the end of 2025/early 2026.
Amgen Plans $1 Billion Manufacturing Expansion in North Carolina
In a move to expand its global biomanufacturing network, US biopharma Amgen is planning to invest $1 billion to build a second drug substance manufacturing facility at its US site in Holy Springs, North Carolina. This brings the company's total planned investment in Holly Springs to more than $1.5 billion, building on its previously announced $550 million commitment.
Lilly Plans $3 Billion Expansion of US Facility in Wisconsin
US drug manufacturer Eli Lilly announced a $3 billion expansion of its US manufacturing facility in Kenosha County, Wisconsin, that the company acquired earlier this year. This investment will extend the company's global parenteral (injectable) product manufacturing network for diabetes, obesity and future medicines across therapeutic areas.
Sanofi to Invest $1 Billion in New Insulin Manufacturing Site in China
Sanofi plans to invest around €1 billion ($1.1 billion) in the construction of a new insulin production facility in Beijing – the company's largest single investment in China to date. This was reported by Reuters and other news agencies.
Givaudan Hikes Encapsulation Technologies Capacity in Mexico
In a move to increase its competitive advantage in Latin America, Swiss flavors, fragrances and active cosmetic ingredients manufacturer Givaudan has inaugurated its newly expanded production facility at the Pedro Escobedo site in Mexico, enhancing the company’s encapsulation technologies.
Air Liquide to Launch New Renewable Hydrogen Production Facility in France
French industrial gases group Air Liquide is launching a renewable hydrogen production project at La Mède, France, to supply TotalEnergies’ biorefinery at that site under a long-term contract. AirLiquide will build, own, and operate the new unit with a capacity of 25,000 t/y, producing hydrogen from recycled biogenic by-products instead of fossil hydrocarbons.
Ube to Increase Capacity for High-Purity Nitric Acid in Japan
Japanese chemical group Ube wants to increase production capacity for high-purity nitric acid at its chemical plant in Ube City, Yamaguchi Prefecture.
Hovione Expands Spray Drying Capacities in the USA and Ireland
Lisbon, Portugal-headquartered Hovione has completed significant expansions in Europe and the USA. The investments at the facilities in East Windsor, New Jersey, and Ringaskiddy, Cork, significantly increase the global capacities of the CDMO (contract development and manufacturing organization) for spray drying for pharma applications and improve the sites' capabilities.
Integrals Power
ACG
Eli Lilly and Company
Ineos
Olon S.p.A.
Novartis International AG
TotalEnergies SE
Axplora
Sanofi S.A.
Sanner GmbH
Curia
Schott Pharma
Roquette
GlaxoSmithKline (GSK) plc
Oxea
Ardena
Arkema
Sygnature Discovery
OCI Global
ISPE D/A/CH e.V.
Evonik Industries AG
Archroma
Moeve Chemicals
International Flavors & Fragrances Inc. (IFF)
Vetter Pharma International GmbH
DuPont Company
Ferrostaal
Chevron Phillips Chemical
Johnson & Johnson
Upperton Pharma Solutions
Biontech
SK Pharmteco
Saltigo GmbH
Yara International ASA
Ineos
Carbios
Celltrion
CF Industries
De Paauw Sustainable Resources (DPSR)
WeylChem International GmbH
Messer Group GmbH
Optex Innovation Center
AFYREN SAS
Kyowa Kirin Co., Ltd.
Novo Nordisk Pharmatech A/S
BASF SE
Lonza AG
Covestro
AmbioPharm, Inc.
Samsung Biologics